The Hematologist

163 - Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.

163 - Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

00:00

Episodios

jue., 09 abr. 2026

lun., 09 mar. 2026

jue., 05 feb. 2026

mié., 22 oct. 2025

jue., 11 sep. 2025

dom., 17 ago. 2025

lun., 28 jul. 2025

lun., 23 jun. 2025

sáb., 24 mayo 2025

vie., 16 mayo 2025

lun., 28 abr. 2025

lun., 31 mar. 2025

jue., 27 feb. 2025

vie., 31 ene. 2025

sáb., 21 dic. 2024

mié., 27 nov. 2024

vie., 11 oct. 2024

lun., 16 sep. 2024

jue., 29 ago. 2024

mié., 17 jul. 2024

mié., 26 jun. 2024

vie., 21 jun. 2024

mar., 07 mayo 2024

lun., 15 abr. 2024

mar., 26 mar. 2024

lun., 18 mar. 2024

mar., 30 ene. 2024

mié., 29 nov. 2023

vie., 20 oct. 2023

lun., 18 sep. 2023

vie., 01 sep. 2023

vie., 07 jul. 2023

vie., 16 jun. 2023

jue., 18 mayo 2023

vie., 21 abr. 2023

mar., 04 abr. 2023

mié., 22 mar. 2023

jue., 16 feb. 2023

vie., 20 ene. 2023

mar., 10 ene. 2023

jue., 22 sep. 2022

mié., 21 sep. 2022

lun., 19 sep. 2022

vie., 01 jul. 2022

mié., 01 jun. 2022

mar., 03 mayo 2022

mié., 13 abr. 2022

The Hematologist

Episodios

Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia

VERONA and the Future of High-Risk Myelodysplastic Syndromes: A Conversation With Dr. Jacqueline Garcia

Leading With Lived Experience: Dr. Brian Koffman, Patient and CEO of the CLL Society

An Homage to the Treg Graft in Allogeneic Transplantation

Less Is More: Low-Dose Direct Oral Anticoagulants for Extended Venous Thromboembolism Prophylaxis in Higher-Risk Patients

GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias

More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists

No Scientific Link Found Between Sickle Cell Trait and Sudden Death

Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

The Rise of the HLA-Mismatched Unrelated Donor Transplant in the U.S.

The End of Transplant for Mantle Cell Lymphoma

DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

Enhancing Risk Stratification for Pediatric B-Cell Acute Lymphoblastic Leukemia: No Longer a ‘PI’ in the Sky Idea?

A Leap of Faith? Elimination of Autologous Stem Cell Transplantation for Patients With Mantle Cell Lymphoma in First Remission

Anticoagulation Stewardship

Blood Global Hematology Editor-in-Chief Shares Vision

One on One With Dr. Fred Appelbaum

Genetic Switch System Suggests Targeting of Mutant JAK2 Reverses Myeloproliferative Neoplasms

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

Growing the Next Generation of Hematologists

Women in Hematology

Four Is Better Than Three: Will We Finally Agree?

Toward Equity in Access for ALL

The Brilliant Success of Blinatumomab for Babies With Acute Lymphoblastic Leukemia

Editors-in-Chief of Two New ASH Journals Share Their Visions

ASH’s Minority Recruitment Initiative Mentorship Program Offers a Win for All

Results From the Blood and Marrow Transplant Trials Network: How Should We Prevent Graft-versus-host Disease in 2023?

Genetic Background Influences the Growth of CHIP Clones Within the Bone Marrow, With Drs. Robert Hasserjian and Siddhartha Jaiswal

Drawing New Blood Into Hematology

Anticoagulation and Abnormal Uterine Bleeding: Acknowledging Calls to Action

ASH | FDA Collaboration: A Workshop on Regulatory Science in Hematology

The Next Wave of T-cell Engagement for the Management of Diffuse Large B-cell Lymphoma, with Drs. Michael Dickinson and Loretta J. Nastoupil

VTE Guidelines for Latin America Special Populations and Diagnosis (Portuguese Audio)

VTE Guidelines for Latin America Special Populations and Diagnosis (Spanish Audio)

VTE Guidelines for Latin America Special Populations and Diagnosis (English Audio)

ASH Summit on Immunotherapies for Hematologic Diseases, With Dr. Terry Fry and Dr. Shaji Kumar

GPRC5D: The Next Frontier for Immunotherapy in Multiple Myeloma, With Drs. Shaji Kumar and Saad Usmani

Should Minimal Residual Disease Guide the Way? With Drs. Partow Kebriaei and Lori Muffly

ASH Celebra el Mes de la Herencia Hispana, Con el Dr. Ruben Mesa, el Dr. Diego Adrianzen-Herrera, & la Dra. Joanna Robles

ASH Celebrates Hispanic Heritage Month, With Drs. Ruben Mesa, Diego Adrianzen-Herrera, & Joanna Robles, Introduced by Dr. Belinda Avalos

Iron-restricted Erythropoiesis in Sickle Cell Disease, With Drs. David Rees, Naja Nyffenegger, & Vania Manolova

ASH and Maternal Health, With Drs. Jennifer Holter-Chakrabarty & Sarah O’Brien

Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy, With Drs. Loretta Nastoupil & Melody Smith

The Latest Sickle Cell Disease Policy Updates, With Drs. Jennifer Holter Chakrabarty & Chancellor Donald

Structural Racism and Understanding Disparities in AML Outcomes, With Drs. Christine McMahon & Ivy Abraham

A Conversation About Women in Medicine, With Drs. Shikha Jain and Laura Michaelis

Más podcasts de

Más podcasts internacionales de